{{Rsnum
|rsid=726640
|Chromosome=1
|position=159685728
|Orientation=minus
|GMAF=0.03719
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 66.0 | 29.3 | 4.8
| ASW | 64.9 | 29.8 | 5.3
| CHB | 100.0 | 0.0 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 76.4 | 21.8 | 1.8
| MEX | 98.3 | 1.7 | 0.0
| MKK | 74.8 | 24.5 | 0.6
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
[[deafness]]
{{omim
|desc=SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND
|id=612780
|rsnum=726640
}}

{{PMID Auto GWAS
|PMID=22492993
|Trait=None
|Title=C-reactive protein (CRP) promoter polymorphisms influence circulating CRP levels in a genome-wide association study of African Americans.
|RiskAllele=
|Pval=2E-13
|OR=0.4400
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}